Investors-Financial Information

Material Information

Material Information Announcement

Click on the Market Observation Post System for public information, where you can search for significant information by year/month. Please enter the code 6782 for Visco Vision Inc. on the page linked.

SEQ_NO 1
Date of announcement 2023/08/10
Time of announcement 17:56:51
To which item it meets paragraph 20
Date of events 2023/08/10
Subject To announce the board resolution on acquisition of common shares of Crystalvue Medical Corp.
Statement
  1. Name of the securities:Crystalvue Medical Corp. common stock(Stock No.6527)
  2. Trading date:2023/08/10~2023/08/10
  3. Amount, unit price, and total monetary amount of the transaction:Amount:Not yet acquired, unable to disclose relevant information
    Unit price:Planned to acquire from Centralized Order Market and will base on market price.
    Total monetary amount of the transaction: no greater than NT$200,000(in thousands)
  4. Gain (or loss) through disposal (not applicable in case of acquisition of securities):N/A
  5. Relationship with the underlying company of the trade:Related party of the company
  6. Current cumulative amount held, monetary amount, and shareholding percentage of cumulative holdings of the securities being traded (including
    the current trade), and status of any restriction of rights (e.g.pledges):
    Current cumulative amount held: 1,655,453 shares
    Monetary amount: NT$102,150(in thousands)
    Shareholding percentage: 6.50%
    Any restriction of rights:N/A
  7. Current ratio of securities investment (including the current trade, as listed in article 3 of Regulations Governing the Acquisition and Disposal of
    Assets by Public Companies) to the total assets and equity attributable to owners of the parent as shown in the most recent financial statement and
    working capital as shown in the most recent financial statement as of the present:2.43%;3.73%;NTD522,910(in thousands)
  8. Concrete purpose of the acquisition or disposal:In accordance with the company's long-term business goal.
  9. Any dissenting opinions of directors to the present transaction:N/A
  10. Whether the counterparty of the current transaction is a related party:Yes
  11. Trading counterparty and its relationship with the Company:N/A
  12. Date of the board of directors resolution:2023/08/10
  13. Date of ratification by supervisors or approval by the audit committee:2023/08/10
  14. Any other matters that need to be specified:N/A